Related Experiment Video
Updated: May 5, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
Practical and translational therapeutic elements for GBM therapy
Seyedeh Elham Norollahi1, Ali Najafizadeh2, Elahe Bakhshalipour2
1Reproductive Health Research Center, Al-Zahra Hospital, Guilan University of Medical Sciences, Rasht, Iran; Medical Biotechnology Research Center, School of Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.
None:
The most malignant tumor of the brain, with a low survival rate, is glioblastoma multiforme. Importantly, routine medical therapeutic techniques do not provide a stable and confident strategy for treatment and diagnosis. In this way, translational elements, including gene therapy, such as suicide gene therapy, tumor suppressor gene therapy, oncolytic virus therapy, nanoparticles, mesenchymal stem cells (MSCs), induced pluripotent stem cells (iPSCs), and aptamers as a new probe in detecting the target structure, are of great importance in GBM therapy. In this review article, we discussed the above elements as a new and practical approach to the diagnosis and treatment of GBM in detail.

